GCS Holdings, Inc. (LUX:GCSH)

Market Cap	547.39M
Revenue (ttm)	52.17M
Net Income (ttm)	-2.94M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	26.60
Day's Range	n/a
52-Week Range	5.10 - 27.40
Beta	n/a
RSI	67.23
Earnings Date	Aug 3, 2025

About Marinus Pharmaceuticals

GCS Holdings, Inc., together with its subsidiaries, manufactures and sells compound semiconductor wafer and foundry related services in China, the United States, Taiwan, and internationally. It also researches, develops, manufactures, and sells optoelectronics technology products and optical chips, as well as grants royalty rights for intellectual property. In addition, the company engages in the wholesaling and retailing of electronic components; provision of product design, research development, and outsourcing management services; manufactur...

• Industry: Electronic Components And Accessories
• Founded: 1997
• Country: Cayman Islands
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: GCSH

Financial Performance

In 2024, GCS Holdings's revenue was 1.75 billion, an increase of 29.57% compared to the previous year's 1.35 billion. Losses were -236.99 million, -70.09% less than in 2023.